Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer

BACKGROUND: Host immunity plays an important role in tumor development and treatment. Tumor‐infiltrating lymphocytes (TILs) have been proven to predict the efficacy of neoadjuvant therapy (NAT) in breast cancer (BC) patients, but their application is limited due to various reasons. This study aims t...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jikun, Yi, Jiarong, Zouxu, Xiazi, Li, Jianxia, Xiong, Zhenchong, Huang, Xinjian, Zhong, Wenjing, Huang, Weiling, Ye, Feng, Wang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359876/
https://www.ncbi.nlm.nih.gov/pubmed/35411609
http://dx.doi.org/10.1002/cam4.4666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359876/
https://www.ncbi.nlm.nih.gov/pubmed/35411609
http://dx.doi.org/10.1002/cam4.4666

Ejemplares similares